Literature DB >> 12580867

Platelet serotonin transporter in stroke patients.

A Rasmussen1, J Christensen, P M Clemmensen, N J Dalsgaard, H Dam, I Hindberg, M Lunde, P Plenge, E Mellerup.   

Abstract

OBJECTIVES: Post-stroke depression can be treated with serotonin transport inhibitors suggesting a role for the serotonin system in these patients. The number of platelet serotonin transporters in stroke patients and in control subjects have been measured in this study.
MATERIAL AND METHODS: Newly admitted stroke patients who did develop or who did not develop a post-stroke depression, non-acute patients who previously had had a stroke and control subjects were compared. The number of platelet serotonin transporters was analysed by ligand binding methodology.
RESULTS: The number of platelet serotonin transporters was low shortly after a stroke compared with normal subjects; no difference was found between the stroke patients who developed a post-stroke depression and those who did not.
CONCLUSION: A low number of platelet serotonin transporters may be a non-specific state marker for a condition as acute stroke.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12580867     DOI: 10.1034/j.1600-0404.2003.02053.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  2 in total

1.  In vitro homocysteine inhibits platelet Na+,K+-ATPase and serum butyrylcholinesterase activities of young rats.

Authors:  Francieli M Stefanello; Renata Franzon; Clovis M D Wannmacher; Moacir Wajner; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2003-12       Impact factor: 3.584

Review 2.  The advances of post-stroke depression: 2021 update.

Authors:  Jianglong Guo; Jinjing Wang; Wen Sun; Xinfeng Liu
Journal:  J Neurol       Date:  2021-05-30       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.